What should I know first?

Serotonin–norepinephrine reuptake inhibitors are called SNRIs. Venlafaxine is one example. Norepinephrine is also known as noradrenaline.

This example uses U.S. Effexor XR extended-release capsules, whose label covers adult depression, generalized anxiety, social anxiety and panic disorder. Other products and age groups need their own information.

This is a mechanism lesson, not a complete medicine guide. A diagram cannot choose treatment, predict your response, or tell you how to change a prescription.

How Brain Cells Communicate

Serotonin and norepinephrine are different messengers. Their transporters return them into nerve cells after release. These are distinct transport systems, even when drawn using the same teaching symbol.

Serotonin · SERT

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Serotonin: The messenger is shown outside the sending cell. SERT: The SERT transporter returns serotonin into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Serotonin

    The messenger is shown outside the sending cell.

  2. SERT

    The SERT transporter returns serotonin into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Separate transporter systems are shown qualitatively. Their relative effects and clinical consequences are not measured by this drawing.
About this illustration

Serotonin and norepinephrine have separate transporters that return messengers into cells. This single symbol introduces the shared task; it does not merge the proteins.

How the Medication Changes Signaling

Venlafaxine and its active breakdown product, O-desmethylvenlafaxine, inhibit serotonin and norepinephrine reuptake in laboratory studies. Inhibiting return changes messenger signaling.

Two targets do not mean exactly equal effects, a fixed ratio, or a universal advantage over an SSRI. This lesson gives no dose threshold for switching mechanisms.

Explore the mechanism

How can one medicine affect two transport systems?

Serotonin · SERT

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Serotonin: The messenger is shown outside the sending cell. SERT: The SERT transporter returns serotonin into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Serotonin

    The messenger is shown outside the sending cell.

  2. SERT

    The SERT transporter returns serotonin into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Static introduction. Separate transporter systems are shown qualitatively. Their relative effects and clinical consequences are not measured by this drawing.

Serotonin · SERT

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Serotonin: The messenger is shown outside the sending cell. SERT: The SERT transporter returns serotonin into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Serotonin

    The messenger is shown outside the sending cell.

  2. SERT

    The SERT transporter returns serotonin into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine · NET

A transporter across a membrane, with the sending-cell interior above and released messenger outside below. The uptake direction is upward. Norepinephrine: The messenger is shown outside the sending cell. NET: The NET transporter returns norepinephrine into the cell. Return into the cell: The arrow shows transport direction, without a measured rate.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The NET transporter returns norepinephrine into the cell.

  3. Return into the cell

    The arrow shows transport direction, without a measured rate.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Before medicine: two systemsSerotonin and norepinephrine have separate transporters that return messengers into cells. This single symbol introduces the shared task; it does not merge the proteins.
A membrane transporter with uptake reduced; messenger remains outside below the membrane. The separate terracotta symbol denotes a medicine, not its molecular shape. Serotonin: The messenger is shown outside the sending cell. SERT: The serotonin transporter returns serotonin into the cell. Venlafaxine: uptake inhibited: The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
  1. Serotonin

    The messenger is shown outside the sending cell.

  2. SERT

    The serotonin transporter returns serotonin into the cell.

  3. Venlafaxine: uptake inhibited

    The interrupted arrow names the action; the symbol is not a molecular shape or binding position.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Serotonin transportVenlafaxine and its active metabolite inhibit serotonin reuptake. The medicine symbol identifies an effect, not an experimentally determined pose.
A membrane transporter with uptake reduced; messenger remains outside below the membrane. The separate terracotta symbol denotes a medicine, not its molecular shape. Norepinephrine: The messenger is shown outside the sending cell. NET: The norepinephrine transporter returns its own messenger into the cell. Venlafaxine: uptake inhibited: The interrupted arrow names the action; the symbol is not a molecular shape or binding position.
  1. Norepinephrine

    The messenger is shown outside the sending cell.

  2. NET

    The norepinephrine transporter returns its own messenger into the cell.

  3. Venlafaxine: uptake inhibited

    The interrupted arrow names the action; the symbol is not a molecular shape or binding position.

Simplified teaching model. Protein shapes, sizes, particle counts and arrows are illustrative, not measurements or experimental structures.

Norepinephrine transportThey also inhibit norepinephrine reuptake. This is a second transport system; the diagram gives no relative strength or dose comparison.

What this model cannot tell us

Clinical mechanism uncertain

  • Clinical mechanism uncertain The clinical explanation remains uncertain.
  • Limits of inference An experimental result does not by itself predict one person’s treatment response.
Limits of the lessonChanging two transport systems does not predict the best medicine for a person. The connection to therapeutic benefit is not fully established.

Static overview. Start the steps when you are ready.

Guide to the illustration: Outlines identify a cell membrane or target; arrows mark the direction explained in each caption. Medicine symbols are labels, not measured shapes or binding poses. No quantity, size or rate is to scale.

Read the complete sequence
  1. Before medicine: two systems. Serotonin and norepinephrine have separate transporters that return messengers into cells. This single symbol introduces the shared task; it does not merge the proteins.
  2. Serotonin transport. Venlafaxine and its active metabolite inhibit serotonin reuptake. The medicine symbol identifies an effect, not an experimentally determined pose.
  3. Norepinephrine transport. They also inhibit norepinephrine reuptake. This is a second transport system; the diagram gives no relative strength or dose comparison.
  4. Limits of the lesson. Changing two transport systems does not predict the best medicine for a person. The connection to therapeutic benefit is not fully established.
Evidence and model limits

Venlafaxine and O-desmethylvenlafaxine studied in vitro. FDA NDA020699 latest linked label verified2026-10-16: August2023.

Separate transporter systems are shown qualitatively. Their relative effects and clinical consequences are not measured by this drawing.

A Closer Look at the Molecular Level

Known action: serotonin and norepinephrine reuptake inhibition is supported by product-specific pharmacology. The active metabolite contributes to this account.

Clinical uncertainty: the label describes the therapeutic mechanism as unclear. The drawing does not explain every benefit or adverse effect, and it does not diagnose a shortage of either messenger.

Sources and References

The sources below support the specific medicine and experimental context described here. Drawings are original qualitative teaching models; positions, arrows and timing do not give atomic geometry, occupancy or rates.

  1. FDA: Effexor XR label, revised August2023
  2. DailyMed: Effexor XR
  3. NIH: What Is a Neurotransmitter?

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top